Notify me when Paul B Manning files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | Common Stock, $0.0001 par value per share | 50% | $28,437,789 | 8,056,031 | Paul B Manning | 25 Nov 2025 | ||
| TSHA | TAYSHA GENE THERAPIES, INC. | Common Stock, $0.00001 par value per share | 9.8% | $59,394,578 | 25,601,111 | Paul B Manning | 30 May 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|